NeuroDigm

NeuroDigm is a preclinical-stage biotechnology company based in Colorado Springs, Colorado, specializing in the development of translational research tools and therapies for chronic neuropathic pain. The company is best known for its proprietary NeuroDigm GEL™ model, a biomimetic, non-surgical animal model that induces persistent neuropathic pain through localized tissue repair and fibrosis rather than direct nerve trauma. This model is designed to more accurately reflect human clinical conditions where pain persists after soft tissue injury without obvious nerve damage. NeuroDigm's primary therapeutic research focuses on the use of targeted recombinant human erythropoietin (EPO) to promote neural regeneration and resolve persistent pain behaviors. The company's mission is to provide researchers with more effective platforms for the discovery and testing of non-opioid analgesics and regenerative biologics.